Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Populations of murine B cells enriched for fluorescein (FLU)- or phosphocholine (PC)-binding cells stimulated with LPS, or FLU- or PC-LPS at low density in 10 microliter cultures form clones of cells that secrete antibodies. Antibody isotypes were determined by radioimmunoassay and their avidities were determined relative to standard, monoclonal antibodies by hapten inhibition using a radioimmunoassay. These analyses further characterize the development of B cell clones in microcultures and reveal that differing culturing conditions stimulate qualitatively different B cell populations to divide and differentiate. Without filler cells, isotype switching is rare. Co-culturing B cells with 10(5) (CBA/N x BALB/c) F1 male thymocyte filler cells leads to IgG and/or
IgA
antibody secretion by 15-20% of cultures; antibodies from clones that switch isotypes are exclusively of high avidity. IgM is almost always present as one clonal product; pre-switched cells rarely score in microcultures. Without filler cells, a high percentage of antibodies from FLU-LPS stimulated, FLU-binding cells are of high avidity (60%). However, clonotypes of lower avidity dominate with mitogenic culture conditions, 100 micrograms/ml LPS or with thymocytes. PC-binding cells are less sensitive to these mitogenic effects. Antibodies produced by PC-specific clones have a more restricted pattern of avidities and resemble in quality anti-PC antibodies produced in vivo.
Mol
Immunol 1988 Mar
PMID:Quality of antibodies secreted by clones in microcultures from B cells enriched on haptenated gelatin: isotypes and avidities. 325 71
Covalent binding of the fourth complement protein, C4, to immune complexes is an important first step in the complement mediated processing of the complexes. Many of the initial encounters between the proteins of the complement system and antigen and antibody occur in solution, and prior to this report, studies of the interactions between them have focused on complement binding to preformed immune precipitates that most likely are not found in vivo. We have characterized the covalent binding of C4b to immunoglobulin molecules in a fluid-phase system consisting only of antibody in solution and purified C4 and C1s. We demonstrate that human C4b binds to IgG in the fluid phase, that its covalent binding is predominantly to the heavy chain of IgG, and that the covalent linkage is by either amide or acyl ester bonds. In addition, we compare the covalent binding efficiencies of two genetic variants of C4, C4A3 and C4B1, to IgG. C4A3 binds 3-4 times more IgG than C4B1 over a range of C4 concentrations, and C4A3 has a higher binding efficiency than C4B1 for IgM,
IgA
, IgG2a and F(ab')2 as well as for a protein antigen, BSA. Furthermore, we found that whereas C4A3 is bound to immunoglobulins in the fluid-phase predominantly by amide linkage, C4B1 is bound by either amide or acyl ester bonds. The results presented here suggest that the covalent binding efficiency of C4A3 and C4B1 to IgG is similar to that reported for their covalent binding to small molecules.
Mol
Immunol 1988 Sep
PMID:The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins. 326 81
Radioimmunoassays for C3a and C4a have been used to measure the activation of complement in human serum by immune complexes containing DNP-BSA and each of 11 mouse anti-DNP monoclonal antibodies of varied isotype and affinity. When preformed complexes were added to serum, those containing IgG2 or IgM were potent activators of C4, whilst IgG1 complexes were less efficient. C3 activation in normal serum was similar for complexes containing IgG1, IgG2a, IgG2b or IgM.
IgA
complexes did not activate C3 or C4. Solubilisation of complexes was greatest for IgM and IgG2b and least for IgG2a and
IgA
. In serum containing Mg2+ EGTA C4 activation was abolished and the amount of C3 activation was lower for all IgG and IgM complexes. Antibodies of the same isotype did not necessarily activate complement to the same extent. Unexpectedly, three of the four IgMs activated C3 in EGTA. For IgMs, neither complement activation nor solubilisation correlated with affinity. For IgG1 antibodies, solubilisation was inversely proportional to affinity. C3 or C4 activation did not correlate with affinity.
Mol
Immunol 1988 Dec
PMID:The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation. 326 94
The interactions of
IgA
with the jackfruit lectin, jacalin, were investigated with regard to the specificity of jacalin for species and subclasses of
IgA
. It was found that jacalin selectively bound to human IgA1, but not to human IgA2, mouse
IgA
or rat
IgA
. Binding studies with human IgA1 fragments produced by different IgA1 proteases revealed that jacalin bound to galactose-terminal oligosaccharides in the hinge region of human IgA1. Affinity chromatography employing jacalin-Sepharose provided a means to separate the subclasses of
IgA
in human whey.
Mol
Immunol 1988 Jan
PMID:Studies on the specificity of the IgA-binding lectin, jacalin. 334 69
Six peptides, representing contiguous amino acid sequences within the C epsilon 2, C epsilon 3 and C epsilon 4 domains of murine IgE, were selected for synthesis on the basis of overall hydropathy, degree of homology to both human and rat IgE and, where possible, inclusion of a native cysteine residue. Antibodies were produced against each peptide by immunizing rabbits with peptide-KLH conjugates. Each anti-peptide antiserum exhibited good reactivity with the corresponding immunizing peptide (titer: 10(-4) to 10(-5] and four of the six antisera exhibited a distinct preferential murine IgE reactivity compared to four other murine immunoglobulin classes (IgG1, IgG2b, IgM and
IgA
). In addition, one antiserum (anti-epsilon peptide 5), raised against a peptide with 80% homology to human IgE, reacted comparably with both human and murine IgE. Each IgE-reactive antiserum was screened for the ability to stimulate mediator release from IgE-sensitized rat basophilic leukemia (RBL) cells. Two of the four IgE-reactive antisera strongly stimulated 3H-serotonin release (anti-epsilon peptides 4 and 5), one antiserum showed weak activity (anti-epsilon peptide 3) and the remaining anti-peptide serum (anti-epsilon peptide 6), which exhibited the highest anti-IgE reactivity, exhibited no detectable stimulatory activity. Individual anti-peptide antibodies were subsequently tested for the potential to bind to receptor-bound IgE. Anti-epsilon peptide 3 was shown to exhibit the least binding, anti-epsilon peptide 6 showed the highest magnitude of binding while anti-epsilon peptides 4 and 5 exhibited intermediate values. We conclude from this study that sequences defined by epsilon-peptides 4 and 5 are not significantly involved in the receptor binding mechanism whereas epsilon-peptide 3 is likely to be most proximal to the IgE-receptor recognition site of those sequences studied. Finally, we suggest that the epsilon-peptide 6 sequence is in such an orientation in cell-bound IgE that, while it is accessible to external antibody, effective cross-linking of the IgE-receptor complex cannot be achieved through this determinant.
Mol
Immunol 1988 Feb
PMID:IgE structure-function relationships defined by sequence directed antibodies induced by synthetic peptides. 337 91
The interaction between the Fc receptor for
IgA
(FcR alpha) and human secretory
IgA
(sIgA) was studied in a heterologous system by using rabbit alveolar macrophages or splenic lymphocytes. The capacity of FcR alpha-bearing cells to interact with the ligand via the Fc region was demonstrated. The proportion of FcR alpha-bearing lymphocytes and macrophages was found to be 11 and 17%, respectively. The cell-bound radiolabelled ligand showed a release half-time of 70 min for lymphocytes and 45 min for macrophages. The equilibrium constant (K) and the maximum number of ligand molecules bound per cell (n) in mean values was 5.2 +/- 0.05 X 10(8) M-1 and 3.3 +/- 0.15 X 10(5) molecules per cell, respectively. Increased percentages of FcR alpha-bearing cells and of ligand density per cell were obtained after stimulation by lung inflammation. A significant increase of the K value was recorded with macrophages from rabbits with lung acute inflammation (mean value 7.3 +/- 0.21 + 10(8) M-1) while the increase with lymphocytes was not significant. The calculation method of K and n is discussed.
Mol
Immunol 1988 Feb
PMID:The Fc receptor for IgA expression and affinity on lymphocytes and macrophages. 337 92
The anti-Lewis alpha mouse immunoglobulin CF4C4 (IgGl, k) Fab has been crystallized from 58% saturated ammonium sulfate in space group Pl; unit cell dimensions a = 43.4 A b = 41.7 A, c = 62.0 A, a = 72.7 degrees, beta = 96.6 degrees, gamma = 100.1 degrees. X-ray diffraction data have been measured beyond 3.0 A Bragg spacing. The crystal structure has been determined by molecular replacement methods, using as search models the constant and variable domains of the mouse immunoglobulin McPC603 (
IgA
, kappa) Fab. The crystallographic residual for the data 5.0 to 4.0 A, is 0.47. The approximate 2-fold axis relating the VL and the VH domains forms an angle of 164 degrees with the 2-fold axis relating the constant domains. The crystal packing is reasonable.
J
Mol
Biol 1987 Nov 20
PMID:Crystal structure of an anti-Lewis alpha Fab determined by molecular replacement methods. 343 Jun 12
When cells of the HL-60 promyelocytic leukemia line are cultured with 1,25-dihydroxyvitamin D3 (calcitriol) they acquire a more highly differentiated, myelomonocytic phenotype. It was observed that the ability to ingest
IgA
-coated erythrocytes and to bind soluble dimeric
IgA
accompanied this maturation. Phagocytosis of
IgA
-coated erythrocytes was greater than 50% inhibited by 0.8 mg/ml free
IgA
, and not by IgG or IgM. Similarly, binding of dimeric
IgA
was not blocked by a 100-fold excess of IgG, IgM or IgE. Both
IgA
-mediated phagocytosis and
IgA
binding became apparent after two days of culture with calcitriol and increased with time in culture. The induction of functional
IgA
receptors was evident with 10(-11) M calcitriol and maximal levels of
IgA
binding and of numbers of cells capable of
IgA
mediated phagocytosis were induced by 10(-8)-10(-9) M calcitriol. 25-Hydroxyvitamin D3, which binds 100-1000-fold less avidly to the cytoplasmic D3 receptor than calcitriol, did not induce functional
IgA
receptors unless concns of 10(-7) M were used. Other compounds which induce differentiation of HL-60 cells, including retinoic acid and DMSO, produced similar results to calcitriol, whereas cells treated with gamma interferon expressed lower levels of
IgA
binding and did not ingest
IgA
-coated targets, suggesting that a critical density of
IgA
receptors must be reached to enable phagocytosis and/or that other cell activational events are required for
IgA
receptors to mediate killing. This model may provide useful insight into the function and regulation of
IgA
receptors on cells of the myeloid series.
Mol
Immunol 1986 Jun
PMID:IgA-mediated effector function of HL-60 cells following treatment with calcitriol. 346 86
The influence of purified human immunoglobulins on the migration of human neutrophils (PMN) was measured in a 48-well micro chemotaxis chamber, with results expressed as percentages of maximal formyl-methionyl-leucyl-phenylalanine (FMLP)-stimulated chemotaxis. Both monomeric and polymeric
IgA
, of both subclasses, in monoclonal and polyclonal form, as well as secretory
IgA
and Fc-alpha, but not Fab-alpha fragments, enhanced PMN migration when present either in the lower or in both compartments of the chamber (chemokinesis) at concns as low as 0.1 mg/ml. IgM and IgE had no such effect. In contrast, IgG was chemotactic at low concn (0.1 mg/ml). Both monomeric and polymeric
IgA
decreased the maximally induced FMLP-chemotaxis, but
IgA
increased chemotaxis induced by suboptimal levels of FMLP. Binding of 3[H]-FMLP to PMN was not affected. Cytofluorographic analysis revealed that, under the conditions of the assay,
IgA
did bind to 93% of PMN. Thus, the various forms of
IgA
have a dual effect on human PMN mobility: (1) increase PMN random migration (chemokinesis); and (2) decrease the maximal FMLP-induced chemotaxis. Our data support the requirement of binding of
IgA
to the Fc-alpha receptor of PMN for expression of these activities. This effect of
IgA
on PMN mobility may be relevant in IgA deficiency states.
Mol
Immunol 1987 Jun
PMID:IgA-induced chemokinesis of human polymorphonuclear neutrophils: requirement of their Fc-alpha receptor. 365 95
The complement-mediated solubilization (CMS) of immunoprecipitates (IP) consisting of DNP-rat serum albumin (RSA) and rat monoclonal anti-DNP antibodies of the
IgA
[both polymeric (p-) and monomeric (m-)] or IgG2b (sub)class was studied. In contrast to IgG2b IP, solubilization of
IgA
IP was only observed in an autologous system, with rat serum as the source of complement. IP prepared using m-
IgA
were solubilized faster than those prepared using p-
IgA
. Analysis of both affinity and avidity of the antibodies, indicated that this difference may be due to the lower avidity of the m-
IgA
antibodies as compared to p-
IgA
. Analysis of the solubilized IP revealed deposition of C3 and C4 on IgG2b, and only C3 on
IgA
IP. These results point toward a role of the alternative pathway in the solubilization of
IgA
IP. Size analysis of the solubilized
IgA
IP employing sucrose density gradient ultracentrifugation, indicated that these were heterogeneous, with a size generally larger than 19 S.
Mol
Immunol 1987 Oct
PMID:Complement-mediated solubilization of rat IgA immune precipitates. 368 2
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>